What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
CIK: 0001841857
Total reported value
$157.4M
$157.4M
69 檔
16.7%
According to the latest 13F quarterly dataset, CM Management, LLC managed an equity portfolio of $157.4M at the end of Q1 2024, spanning 69 distinct U.S. exchange-listed positions.
During Q1 2024, CM Management, LLC's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ALCO | Alico Inc | Stock-Other | 5.29% | -1.64% | — | |
| 2 | TGB | Taseko Mines LTD | Stock-Other | 4.56% | — | — | |
| 3 | AM6 | Amicus Therapeutics Inc | Stock-Other | 4.45% | — | — | |
| 4 | RPRX | Royalty Pharma plc | Stock-Healthcare | 4.08% | -0.56% | +28.00% | |
| 5 | NMRK | Newmark Group Inc-class A | Stock-Other | 3.73% | -0.46% | — | |
| 6 | RLGT | Radiant Logistics Inc | Stock-Other | 3.30% | -0.10% | +5.07% | |
| 7 | IOVA | Iovance Biotherapeutics Inc | Stock-Other | 3.11% | -0.13% | — | |
| 8 | AMSC | American Superconductor CORP | Stock-Other | 2.84% | — | +28.21% | |
| 9 | PLPC | Preformed Line Products Co | Stock-Other | 2.81% | — | +48.57% | |
| 10 | KD | Kyndryl Holdings Inc | Stock-Tech | 2.56% | — | — | |
| 11 | WBA | Walgreens Boots Alliance Inc | Stock-Other | 2.55% | — | +115.38% | |
| 12 | INTT | Intest CORP | Stock-Other | 2.50% | -3.77% | EXIT | |
| 13 | RIGLUSD | Rigel Pharmaceuticals Inc | Stock-Other | 2.49% | — | +17.65% | |
| 14 | PD | Pagerduty Inc | Stock-Other | 2.29% | +0.23% | — | |
| 15 | CLPT | Clearpoint Neuro Inc | Stock-Other | 2.14% | +0.28% | +87.50% | |
| 16 | ARKR | Ark Restaurants CORP | Stock-Other | 2.13% | -0.39% | — | |
| 17 | BGC | Bgc Group Inc-a | Stock-Financials | 2.12% | -0.62% | -43.48% | |
| 18 | CHRS | Coherus Oncology Inc | Stock-Other | 2.01% | -1.10% | +21.36% | |
| 19 | VTRS | Viatris Inc | Stock-Healthcare | 2.01% | -0.21% | — | |
| 20 | OGN | Organon & Co | Stock-Healthcare | 1.97% | +0.36% | — | |
| 21 | EOLS | Evolus Inc | Stock-Other | 1.76% | +0.39% | — | |
| 22 | SVC | Service Properties Trust | Stock-Other | 1.71% | -0.19% | +20.00% | |
| 23 | ARKO | Arko CORP | Stock-Other | 1.70% | +0.05% | +18.03% | |
| 24 | BB3 | Brookline Bancorp Inc | Stock-Other | 1.51% | — | — | |
| 25 | WBD | Warner Bros Discovery Inc | Stock-Comm Services | 1.47% | — | +60.00% | |
| 26 | TALO | Talos Energy Inc | Stock-Other | 1.46% | +0.62% | NEW | |
| 27 | INCY | Incyte CORP | Stock-Healthcare | 1.44% | — | — | |
| 28 | BIDU | Baidu Inc - Spon Adr | Stock-Comm Services | 1.33% | — | — | |
| 29 | FHN | First Horizon CORP | Stock-Financials | 1.29% | — | +100.00% | |
| 30 | RBCAA | Republic Bancorp Inc-class A | Stock-Other | 1.29% | -0.05% | +9.09% | |
| 31 | PAAS | Pan American Silver CORP | Stock-Materials | 1.27% | — | — | |
| 32 | JAZZ | Jazz Pharmaceuticals plc | Stock-Healthcare | 1.26% | — | — | |
| 33 | CGAU | Centerra Gold Inc | Stock-Other | 1.24% | — | +66.67% | |
| 34 | DIT | Amcon Distributing Co | Stock-Other | 1.24% | -0.40% | — | |
| 35 | BABA | Alibaba Group Holding-sp Adr | Stock-Consumer Disc | 1.22% | — | — | |
| 36 | NWL | Newell Brands Inc | Stock-Consumer Staples | 1.18% | +0.21% | — | |
| 37 | PFE | Pfizer Inc | Stock-Healthcare | 1.17% | +0.31% | NEW | |
| 38 | ABX | Barrick Gold CORP | Stock-Financials | 1.12% | — | +60.00% | |
| 39 | XOMA | Xoma Royalty Corporation | Stock-Other | 1.11% | -1.05% | EXIT | |
| 40 | CRIS | Curis Inc | Stock-Other | 1.10% | +0.11% | +380.00% | |
| 41 | RVNCEUR | Revance Therapeutics Inc | Stock-Other | 1.03% | — | +233.33% | |
| 42 | SABR | Sabre CORP | Stock-Tech | 1.02% | -0.02% | +66.67% | |
| 43 | AVIR | Atea Pharmaceuticals Inc | Stock-Other | 0.92% | -0.55% | — | |
| 44 | COYA | Coya Therapeutics Inc | Stock-Other | 0.83% | +0.25% | — | |
| 45 | NKTREUR | Nektar Therapeutics | Stock-Other | 0.74% | — | — | |
| 46 | PK | Park Hotels & Resorts Inc | Stock-Real Estate | 0.73% | -0.39% | -16.67% | |
| 47 | HRTX | Heron Therapeutics Inc | Stock-Other | 0.70% | -0.40% | -7.69% | |
| 48 | CTSO | Cytosorbents CORP | Stock-Other | 0.66% | -0.35% | +98.80% | |
| 49 | ACAD | Acadia Pharmaceuticals Inc | Stock-Healthcare | 0.62% | — | +33.33% | |
| 50 | BATL | Battalion Oil CORP | Stock-Other | 0.62% | — | +20.04% |
According to official SEC Form 13F filings, CM Management, LLC reported a total U.S. public equity portfolio value of $157.4M across 69 disclosed positions in Q1 2024.
During Q1 2024, CM Management, LLC's top holdings by market value included ALCO (5.3%)、TGB (4.6%)、AM6 (4.5%). The largest single position, ALCO, represented 5.3% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including ALCO, TGB, AM6) accounted for 16.7% of total reported equity market value during Q1 2024.
In Q1 2024, CM Management, LLC made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.